Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.96−0.01 (-0.51%)
Close on Nov 13, 2026Market cap $609.23MP/E –Yield 0.00%
Pacific Biosciences of California profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pacific Biosciences of California's profit margin for the twelve months ending Sep 30, 2026 was -81.3%. For fiscal 2025 it was -341.5%, against -201.2% the year before. The highest annual figure on record is 37.3% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -341.5% | −140.3 |
| FY2024 | Dec 31, 2024 | -201.2% | −48.2 |
| FY2023 | Dec 31, 2023 | -153.0% | +92.0 |
| FY2022 | Dec 31, 2022 | -244.9% | −106.1 |
| FY2021 | Dec 31, 2021 | -138.9% | −176.1 |
| FY2020 | Dec 31, 2020 | 37.3% | +129.8 |
| FY2019 | Dec 31, 2019 | -92.6% | +37.9 |
| FY2018 | Dec 31, 2018 | -130.4% | −31.8 |
| FY2017 | Dec 31, 2017 | -98.6% | −16.6 |
| FY2016 | Dec 31, 2016 | -82.0% | −47.8 |
| FY2015 | Dec 31, 2015 | -34.2% | +75.0 |
| FY2014 | Dec 31, 2014 | -109.2% | +172.2 |
| FY2013 | Dec 31, 2013 | -281.4% | +82.2 |
| FY2012 | Dec 31, 2012 | -363.6% | −40.5 |
| FY2011 | Dec 31, 2011 | -323.0% | +8050.1 |
| FY2010 | Dec 31, 2010 | -8373.1% | +56592.1 |
| FY2009 | Dec 31, 2009 | -64965.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -93.3% | +5.6 |
| Q2 FY2026 | Jun 30, 2026 | -114.7% | −9.3 |
| Q1 FY2026 | Mar 31, 2026 | -22.3% | +1124.6 |
| Q4 FY2025 | Dec 31, 2025 | -90.4% | −96.5 |
| Q3 FY2025 | Sep 30, 2025 | -98.9% | +53.1 |
| Q2 FY2025 | Jun 30, 2025 | -105.4% | +375.8 |
| Q1 FY2025 | Mar 31, 2025 | -1146.8% | −945.4 |
| Q4 FY2024 | Dec 31, 2024 | 6.0% | +146.6 |
| Q3 FY2024 | Sep 30, 2024 | -151.9% | −31.9 |
| Q2 FY2024 | Jun 30, 2024 | -481.3% | −334.5 |
| Q1 FY2024 | Mar 31, 2024 | -201.4% | +24.8 |
| Q4 FY2023 | Dec 31, 2023 | -140.5% | +168.0 |
| Q3 FY2023 | Sep 30, 2023 | -120.1% | +118.1 |
| Q2 FY2023 | Jun 30, 2023 | -146.8% | +54.5 |
| Q1 FY2023 | Mar 31, 2023 | -226.3% | +19.4 |
| Q4 FY2022 | Dec 31, 2022 | -308.5% | −116.0 |
| Q3 FY2022 | Sep 30, 2022 | -238.2% | −285.6 |
| Q2 FY2022 | Jun 30, 2022 | -201.3% | −67.4 |
| Q1 FY2022 | Mar 31, 2022 | -245.7% | +55.9 |
| Q4 FY2021 | Dec 31, 2021 | -192.5% | −468.6 |
| Q3 FY2021 | Sep 30, 2021 | 47.4% | +171.7 |
| Q2 FY2021 | Jun 30, 2021 | -133.9% | −13.0 |
| Q1 FY2021 | Mar 31, 2021 | -301.5% | −309.6 |
| Q4 FY2020 | Dec 31, 2020 | 276.1% | +276.5 |
| Q3 FY2020 | Sep 30, 2020 | -124.2% | +8.6 |
| Q2 FY2020 | Jun 30, 2020 | -121.0% | −21.1 |
| Q1 FY2020 | Mar 31, 2020 | 8.1% | +192.7 |
| Q4 FY2019 | Dec 31, 2019 | -0.3% | +157.4 |
| Q3 FY2019 | Sep 30, 2019 | -132.9% | +5.0 |
| Q2 FY2019 | Jun 30, 2019 | -99.9% | +4.6 |
| Q1 FY2019 | Mar 31, 2019 | -184.6% | −59.7 |
| Q4 FY2018 | Dec 31, 2018 | -157.7% | −74.5 |
| Q3 FY2018 | Sep 30, 2018 | -137.9% | −44.4 |
| Q2 FY2018 | Jun 30, 2018 | -104.5% | +22.8 |
| Q1 FY2018 | Mar 31, 2018 | -124.9% | −29.1 |
| Q4 FY2017 | Dec 31, 2017 | -83.3% | −9.3 |
| Q3 FY2017 | Sep 30, 2017 | -93.5% | – |
| Q2 FY2017 | Jun 30, 2017 | -127.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -95.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -74.0% | – |
See a number that looks wrong?